Sleep Number (SNBR) Q2 2025 Earnings Transcript

Sleep Number reported Q2 net sales of $328 million, down 19.7% year over year, as a deliberate 30% cut in marketing spend weighed on demand. Gross margin held flat at 59.1% and adjusted EBITDA was $23.6 million, but the company guided to full-year net sales of about $1.45 billion, down 14%, alongside roughly $130 million in 2025 operating expense reductions and $8 million more restructuring costs expected. Management said it is in active discussions with lenders while targeting breakeven cash flow in the second half and gross margin of about 61% in the back half.

Analysis

The key read-through is that SNBR is no longer primarily a demand story; it is a balance-sheet constrained operating turnaround where management is intentionally sacrificing near-term revenue to prove control of the cost base. That usually helps equity only if the marketing reset truly lowers CAC on a durable basis, because once the easy expense cuts are harvested, the model will need top-line inflection to avoid a classic margin plateau. The 24% conversion improvement matters more than the headline sales decline — if that persists into the fall, the market may start to price in a 2026 re-acceleration rather than a permanent shrinkage path.

The deeper risk is that the company is simultaneously trying to re-price the product, simplify the funnel, and expand distribution while operating under covenant pressure. That combination often creates execution slippage: broader channel access can dilute pricing power, while a simpler assortment can cannibalize premium mix before new SKUs prove themselves. The most important second-order effect is on suppliers and lenders, not just consumers — if management needs more flexibility, vendor terms and covenant amendments become a hidden source of EBITDA support, but they also telegraph that true free-cash-flow durability is still unproven.

Contrarianly, the market may be underestimating how much of the current reset is actually a positive setup for 2H25 margin optics and 1H26 sentiment, even if the business remains structurally challenged. But the stock is also vulnerable to any sign that the conversion gains are promotional rather than structural, because then the company would have traded revenue for temporary efficiency without fixing the underlying brand consideration problem. In that scenario, the equity rerates lower quickly once investors conclude the cost cuts are exhausted and the only lever left is leverage management.

Key Decisions for Investors

• Stay short SNBR on any post-earnings relief rally; prefer 4-8 week horizon into the next sales read-through. Risk/reward: ~15-20% downside if the market starts pricing covenant/refi overhang and fading cost cuts, vs limited upside unless conversion gains become visible in actual same-store or channel trend data.
• For more defined risk, buy SNBR puts 2-3 months out with strikes near current trading levels or slightly out-of-the-money. Thesis: if 2H sales merely track guidance and the market focuses on leverage rather than margin, equity could de-rate faster than fundamentals improve.
• Pair trade: long a higher-quality home/furniture or durable consumer name with steadier demand, short SNBR. The objective is to isolate idiosyncratic execution risk and avoid being paid only for broad consumer softness; SNBR should underperform if marketing efficiency fails to convert into durable traffic.
• Do not chase the bull case until there is evidence of sustained traffic recovery outside management commentary; wait for a second-quarter-like conversion trend plus better sell-through data in the next quarter. If that confirms, the stock can work as a tactical long, but not before.
• For risk-tolerant investors, consider a small call spread only after lenders grant tangible flexibility. That is the cleanest catalyst for multiple expansion; absent a covenant/refi announcement, upside is likely capped by balance-sheet discounting.